Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride is a safe and effective long-term treatment for male hair loss, especially when started early.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Men with androgenetic alopecia (hair loss) are more likely to have fatty liver disease than those without hair loss.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Combining PRP and minoxidil is more effective for hair loss than using either alone.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Finasteride is effective and safe for long-term treatment of hair loss in Japanese men.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.